A Randomized, Double-Blind, Placebo Controlled Vaccination-Challenge Study of ACE393 to Determine Efficacy Against the Symptoms of Moderate to Severe Campylobacter Jejuni Infection in Normal Healthy Volunteers
The purpose of this study is to determine whether ACE393 vaccination can protect against Campylobacteriosis in a challenge model.